ES75
TEAS SECTION 71 & 15 RECEIVED
07/24/2026
Back to search
Official data from USPTO
EMPA-REG OUTCOME
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
07/24/2026
Trademark type
Combined
Nice classes
41, 42
Filing date
11/19/2015
Registration date
08/30/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/13/2023
Last transaction
07/24/2026
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
DE
Examiner
SETTLES LEWIS, SHAILA E
Law office
M50
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of the wording "EMPA-REG" in capitalized gray letters slightly larger and above the word "OUTCOME" also in gray capital letters. To the left of the wording is an abstract design comprised of several circles of various sizes forming a ring with an irregular circumference, with the circles in the colors red, blue, gray and violet.
Holders and representatives
Holders
Boehringer Ingelheim International GmbH
Representatives
Kathryn M. Eyster Tepper & Eyster, PLLC
Technical classification
Nice Classes
Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 41
Publication of printed matter with the results of clinical studies concerning pharmaceutical preparations
Class 42
Medical and scientific research in the field of diabetes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Publications
History of USPTO decisions and trademark events.
36 publications found
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
08/30/2025
RNWL
INTERNATIONAL REGISTRATION RENEWED
08/28/2025
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
01/13/2023
71AG
REGISTERED-SEC.71 ACCEPTED
01/13/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/23/2022
ES71
TEAS SECTION 71 RECEIVED
06/14/2022
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
08/30/2021
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
01/06/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/19/2016
FIMP
FINAL DISPOSITION PROCESSED
12/19/2016
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/30/2016
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
09/19/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
08/30/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/14/2016
PUBO
PUBLISHED FOR OPPOSITION
06/14/2016
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/01/2016
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/01/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/25/2016
RFNT
REFUSAL PROCESSED BY IB
05/13/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/12/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/05/2016
ALIE
ASSIGNED TO LIE
05/05/2016
PAPER RECEIVED
04/22/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/20/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/19/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/19/2016
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/31/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/22/2016
RFRR
REFUSAL PROCESSED BY MPU
03/22/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/21/2016
CNRT
NON-FINAL ACTION WRITTEN
03/20/2016
DOCK
ASSIGNED TO EXAMINER
03/13/2016
MAFR
APPLICATION FILING RECEIPT MAILED
03/01/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/26/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/25/2016
Continuous trademark protection
Get notified about every new filing that threatens EMPA-REG OUTCOME or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.